Immunization of the Female Genital Tract with a DNA-Based Vaccine

Immunization of the female genital tract with a DNA-based vaccine.

Vaccines are being sought for contraception and the prevention of sexually transmitted diseases. However, progress is slow in this area largely because of lack of information on induction of protective immune responses in genital tract mucosa. In this study, we investigated whether in vivo transfection with a model DNA-based antigen delivered by gene gun technology would induce an antibody resp...

Non-Hodgekin’s lymphoma of female genital tract: a case report

Non–Hodgkin lymphoma (NHL) causes many deaths worldwide with increasing incidence. Non-Hodgkin's lymphoma (NHL) may involve the gynecologic tract, and the ovary to be one of the commoner anatomic sites as reported. Ovarian involvement by NHL is usually secondary, occurring as a part of systemic disease. The diagnosis is often made incidentally while investigating for gynecological symptoms. We ...

Female Genital Tract Tumors

Female Genital Tract Cysts

Cystic diseases in the female pelvis are common. Cysts of the female genital tract comprise a large number of physiologic and pathologic cysts. The majority of cystic pelvic masses originate in the ovary, and they can range from simple, functional cysts to malignant ovarian tumors. Non-ovarian cysts of female genital system are appeared at least as often as ovarian cysts. In this review, we aim...

Chlamydia A in the female genital tract.

The first genital tract isolates of Chlamydia A were obtained from parents of babies suffering from TRIC ophthalmia neonatorum, by growth in the yolk sac of fertile eggs 1964). It was noted that the fathers of these babies were frequently suffering from non-gonococcal urethritis (NGU) and that the mothers often showed changes in the cervix. The isolation of Chlamydia from two of nine un-selecte...